These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Editorial: Prevention of tetanus. Med J Aust; 1973 Aug; 2(7):303. PubMed ID: 4795735 [No Abstract] [Full Text] [Related]
3. [Tetanus prophylaxis using purified hyperimmune sera. 1. Study of proteolysed equine antitoxin catabolism in laboratory animals]. Depelchin A Ann Inst Pasteur (Paris); 1972 Nov; 123(5):681-94. PubMed ID: 4573184 [No Abstract] [Full Text] [Related]
4. [Current trends in the use of combined serum and vaccine in tetanus prevention]. Olivo R; Fabio U Boll Ist Sieroter Milan; 1980 Nov; 59(5):455-63. PubMed ID: 7248074 [TBL] [Abstract][Full Text] [Related]
5. Comparative trial of three heterologous anti-tetanus sera. Sinclair IS; McCormick JS; Clark JG J Hyg (Lond); 1971 Jun; 69(2):201-7. PubMed ID: 5282924 [TBL] [Abstract][Full Text] [Related]
7. Comparison of oil adjuvant and aluminium phosphate-adsorbed toxoid for the passive immunization of lambs against tetanus. Cameron CM; Van Biljon BJ; Botha WJ; Knoetze PC Onderstepoort J Vet Res; 1983 Sep; 50(3):229-31. PubMed ID: 6646665 [TBL] [Abstract][Full Text] [Related]
8. [Medicolegal responsibility in the carrying out of active and passive prevention of tetanus]. Mangili F Boll Ist Sieroter Milan; 1980 Nov; 59(5):503-5. PubMed ID: 7248080 [TBL] [Abstract][Full Text] [Related]
9. [Studies on heterologous antilymphocyte sera and their importance for organ transplantation]. Pichlmayr R Med Klin; 1966 Jun; 61(22):895-6. PubMed ID: 5997062 [No Abstract] [Full Text] [Related]
10. [The use of passive hemagglutination with turkey erythrocytes for the effective prevention of tetanus in wounded patients]. Bistoni F; Pitzurra M; Marconi P Boll Ist Sieroter Milan; 1983; 62(6):575-9. PubMed ID: 6677271 [TBL] [Abstract][Full Text] [Related]
11. [Experiments on production of antitetanus immune serum from sheep]. OLAH P Kiserl Orvostud; 1956 Feb; 8(1):6-12. PubMed ID: 13332865 [No Abstract] [Full Text] [Related]
12. [Production and use of hyperimmune heterologous horse serum against colibacteriosis in swine]. Dobrev V; Vachev B; Peshev S; Mitov S Vet Med Nauki; 1982; 19(1):41-6. PubMed ID: 7051528 [No Abstract] [Full Text] [Related]
13. Comparative evaluation of the medicinal and prophylactic properties of the antitetanic and antigangrenous sera obtained from cattle and horses. SHCHEPETOV FN Zh Mikrobiol Epidemiol Immunobiol; 1945; (7-8):29-32. PubMed ID: 20984540 [No Abstract] [Full Text] [Related]
14. [Human serum in the treatment of tetanus]. Ellis M Rass Int Clin Ter; 1967 Mar; 47(6):335-6. PubMed ID: 5607581 [No Abstract] [Full Text] [Related]
15. A.T.S. as a prophylactic measure in cases of wounds resulting from road or industrial accidents. J Indian Med Assoc; 1972 Sep; 59(6):260. PubMed ID: 4676478 [No Abstract] [Full Text] [Related]
16. Production of antitetanus serum in cattle. OLAH P Acta Microbiol Acad Sci Hung; 1954; 2(1-2):91-103. PubMed ID: 14375834 [No Abstract] [Full Text] [Related]
17. [Passive tetanus immunization in the aged with human immunoglobulin]. Erdös G; Erdös L; Bíró J Orv Hetil; 1981 Jan; 122(1):29-32. PubMed ID: 7220038 [No Abstract] [Full Text] [Related]
18. [Counter-indications of antitetanus vaccination]. Vincent P; Monier P J Med Lyon; 1969 Feb; 50(159):281-3. PubMed ID: 4238548 [No Abstract] [Full Text] [Related]
19. The effect of different quantities and compositions of pelleted diets on immune response of mares during the production of anti-tetanus sera. Rupić V; Bacar-Huskić L; Lojkić M; Habe F; Ergotić N Berl Munch Tierarztl Wochenschr; 2001; 114(5-6):188-92. PubMed ID: 11413712 [TBL] [Abstract][Full Text] [Related]
20. [Use of dry antitetanus plasma in complex treatment of patients with tetanus]. Malyĭ GP Vrach Delo; 1967 Jan; 1():95-7. PubMed ID: 5617212 [No Abstract] [Full Text] [Related] [Next] [New Search]